{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T03:42:03Z","timestamp":1776224523227,"version":"3.50.1"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T00:00:00Z","timestamp":1721779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T00:00:00Z","timestamp":1721779200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetes Ther"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1007\/s13300-024-01623-5","type":"journal-article","created":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T09:05:27Z","timestamp":1721811927000},"page":"1845-1854","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Intentional Insulin Overdose and Depression in Subjects with and Without Diabetes Mellitus: A Commentary"],"prefix":"10.1007","volume":"15","author":[{"given":"Evanthia","family":"Gouveri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aikaterini","family":"Gkouveri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Djordje S.","family":"Popovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitrios","family":"Papazoglou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7320-785X","authenticated-orcid":false,"given":"Nikolaos","family":"Papanas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,7,24]]},"reference":[{"key":"1623_CR1","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1093\/qjmed\/93.6.351","volume":"93","author":"K Hawton","year":"2000","unstructured":"Hawton K, Clements A, Simkin S, Malmberg M. Doctors who kill themselves: a study of methods used for suicide. Q J Med. 2000;93:351\u20137.","journal-title":"Q J Med"},{"key":"1623_CR2","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1001\/jama.1934.62750100002009a","volume":"102","author":"JT Beardwood","year":"1934","unstructured":"Beardwood JT. A case of attempted suicide with insulin. JAMA. 1934;102:765.","journal-title":"JAMA"},{"key":"1623_CR3","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3390\/toxics10030123","volume":"10","author":"S Rzepczyk","year":"2022","unstructured":"Rzepczyk S, Doli\u0144ska-Kaczmarek K, Uruska A, \u017baba C. The other face of insulin-overdose and its effects. Toxics. 2022;10:123.","journal-title":"Toxics"},{"key":"1623_CR4","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3389\/fpsyt.2017.00040","volume":"8","author":"C Conti","year":"2017","unstructured":"Conti C, Mennitto C, Di Francesco G, et al. Clinical characteristics of diabetes mellitus and suicide risk. Front Psychiatry. 2017;8:40.","journal-title":"Front Psychiatry"},{"key":"1623_CR5","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s12024-022-00511-3","volume":"18","author":"L Stephenson","year":"2022","unstructured":"Stephenson L, van den Heuvel C, Humphries M, Byard RW. Characteristics of fatal insulin overdoses. Forensic Sci Med Pathol. 2022;18:429\u201341.","journal-title":"Forensic Sci Med Pathol"},{"key":"1623_CR6","doi-asserted-by":"publisher","first-page":"58","DOI":"10.5694\/j.1326-5377.1977.tb130503.x","volume":"1","author":"FI Martin","year":"1977","unstructured":"Martin FI, Hansen N, Warne GL. Attempted suicide by insulin overdose in insulin-requiring diabetics. Med J Aust. 1977;1:58\u201360.","journal-title":"Med J Aust"},{"key":"1623_CR7","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.2337\/dc14-0005","volume":"37","author":"RT Webb","year":"2014","unstructured":"Webb RT, Lichtenstein P, Dahlin M, et al. Unnatural deaths in a national cohort of people diagnosed with diabetes. Diabetes Care. 2014;37:2276\u201383.","journal-title":"Diabetes Care"},{"key":"1623_CR8","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1097\/00005650-200412000-00009","volume":"42","author":"WJ Katon","year":"2004","unstructured":"Katon WJ, Simon G, Russo J, et al. Quality of depression care in a population-based sample of patients with diabetes and major depression. Med Care. 2004;42:1222\u20139.","journal-title":"Med Care"},{"key":"1623_CR9","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1177\/0957154X211062538","volume":"33","author":"R Freudenthal","year":"2022","unstructured":"Freudenthal R, Moncrieff J. A landmark in psychiatric progress\u2019? The role of evidence in the rise and fall of\u00a0insulin\u00a0coma\u00a0therapy. Hist Psychiatry. 2022;33:65\u201378.","journal-title":"Hist Psychiatry"},{"key":"1623_CR10","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.2337\/diacare.16.8.1167","volume":"16","author":"JA Gavard","year":"1993","unstructured":"Gavard JA, Lustman PJ, Clouse RE. Prevalence of depression in adults with diabetes. An epidemiological evaluation. Diabetes Care. 1993;16:1167\u201378.","journal-title":"Diabetes Care"},{"key":"1623_CR11","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.2337\/diacare.24.6.1069","volume":"24","author":"RJ Anderson","year":"2001","unstructured":"Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care. 2001;24:1069\u201378.","journal-title":"Diabetes Care"},{"key":"1623_CR12","doi-asserted-by":"publisher","first-page":"258","DOI":"10.4088\/PCC.09r00802","volume":"11","author":"KS Russell","year":"2009","unstructured":"Russell KS, Stevens JR, Stern TA. Insulin overdose among patients with diabetes: a readily available means of suicide. Prim Care Companion J Clin Psychiatry. 2009;11:258\u201362.","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"1623_CR13","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1586\/eem.09.2","volume":"4","author":"B Mezuk","year":"2009","unstructured":"Mezuk B, Golden SH. A link between depression and bone metabolism: what are the implications for treatment? Expert Rev Endocrinol Metab. 2009;4:199\u2013202.","journal-title":"Expert Rev Endocrinol Metab"},{"issue":"Suppl","key":"1623_CR14","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.1016\/S0165-0327(12)70004-6","volume":"142","author":"T Roy","year":"2012","unstructured":"Roy T, Lloyd CE. Epidemiology of depression and diabetes: a systematic review. J Affect Disord. 2012;142(Suppl):S8-21.","journal-title":"J Affect Disord"},{"key":"1623_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2023.101505","volume":"50","author":"S Kim","year":"2024","unstructured":"Kim S, Kim G, Cho SH, et al. Increased risk of incident mental disorders in adults with new-onset type 1 diabetes diagnosed after the age of 19: a nationwide cohort study. Diabetes Metab. 2024;50: 101505.","journal-title":"Diabetes Metab"},{"key":"1623_CR16","first-page":"837","volume":"49","author":"MJ Knol","year":"2006","unstructured":"Knol MJ, Twisk JW, Beekman AT, et al. Depression as a risk factor for the onset of type 2 diabetes mellitus. A Meta-Anal Diabetol. 2006;49:837\u201345.","journal-title":"A Meta-Anal Diabetol"},{"key":"1623_CR17","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S0891-8422(02)00019-8","volume":"19","author":"SM Walsh","year":"2002","unstructured":"Walsh SM, Sage RA. Depression and chronic diabetic foot disability. A case report of suicide. Clin Podiatr Med Surg. 2002;19:493\u2013508.","journal-title":"Clin Podiatr Med Surg"},{"key":"1623_CR18","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1097\/00005792-198509000-00004","volume":"64","author":"R Arem","year":"1985","unstructured":"Arem R, Zoghbi W. Insulin overdose in eight patients: insulin pharmacokinetics and review of the literature. Medicine (Baltimore). 1985;64:323\u201332.","journal-title":"Medicine (Baltimore)"},{"key":"1623_CR19","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1542\/peds.81.4.526","volume":"81","author":"Y Kaminer","year":"1988","unstructured":"Kaminer Y, Robbins DR. Attempted suicide by insulin overdose in insulin-dependent diabetic adolescents. Pediatrics. 1988;81:526\u20138.","journal-title":"Pediatrics"},{"key":"1623_CR20","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1136\/bmj.285.6339.408","volume":"285","author":"IW Campbell","year":"1982","unstructured":"Campbell IW, Ratcliffe JG. Suicidal insulin overdose managed by excision of insulin injection site. Br Med J (Clin Res Ed). 1982;285:408\u20139.","journal-title":"Br Med J (Clin Res Ed)"},{"key":"1623_CR21","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.2169\/internalmedicine.43.1056","volume":"43","author":"D Uchida","year":"2004","unstructured":"Uchida D, Ohigashi S, Hikita S, et al. Acute pulmonary edema caused by hypoglycemia due to insulin overdose. Intern Med. 2004;43:1056\u20139.","journal-title":"Intern Med"},{"key":"1623_CR22","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1111\/pedi.12210","volume":"17","author":"M White","year":"2016","unstructured":"White M, Zacharin MR, Werther GA, Cameron FJ. Intravenous glucagon in a deliberate insulin overdose in an adolescent with type 1 diabetes mellitus. Pediatr Diabetes. 2016;17:66\u20139.","journal-title":"Pediatr Diabetes"},{"key":"1623_CR23","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3389\/fpsyt.2020.00089","volume":"11","author":"D Stein","year":"2020","unstructured":"Stein D, Keller S, Ifergan IS, et al. Extreme risk taking behaviors in patients with eating disorders. Front Psychiatry. 2020;11:89.","journal-title":"Front Psychiatry"},{"key":"1623_CR24","doi-asserted-by":"publisher","DOI":"10.12659\/AJCR.920078","volume":"21","author":"Y Miyakuni","year":"2020","unstructured":"Miyakuni Y, Nakajima M, Kaszynski RH, et al. A case involving massive insulin overdose: direct and indirect conditions requiring extended management of serum potassium. Am J Case Rep. 2020;21: e920078.","journal-title":"Am J Case Rep"},{"key":"1623_CR25","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1136\/bmj.287.6387.249","volume":"287","author":"H Gin","year":"1983","unstructured":"Gin H, Larnaudie B, Aubertin J. Attempted suicide by insulin injection treated with artificial pancreas. Br Med J (Clin Res Ed). 1983;287:249\u201350.","journal-title":"Br Med J (Clin Res Ed)"},{"key":"1623_CR26","doi-asserted-by":"publisher","first-page":"333","DOI":"10.4103\/0976-500X.103694","volume":"3","author":"FS Do\u011fan","year":"2012","unstructured":"Do\u011fan FS, Onur OE, Alt\u0131nok AD, G\u00f6neysel O. Insulin glargine overdose. J Pharmacol Pharmacother. 2012;3:333\u20135.","journal-title":"J Pharmacol Pharmacother"},{"key":"1623_CR27","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1111\/j.1742-1241.1990.tb10195.x","volume":"44","author":"JG Flood","year":"1990","unstructured":"Flood JG, Williams TD, Bacon RC. Full recovery following massive overdose with insulin and thyroxine. Br J Clin Pract. 1990;44:747\u20138.","journal-title":"Br J Clin Pract"},{"key":"1623_CR28","doi-asserted-by":"publisher","first-page":"255","DOI":"10.2337\/diacare.10.2.255","volume":"10","author":"E Hsi","year":"1987","unstructured":"Hsi E, Werner PL. An unusual case of insulin overdose. Diabetes Care. 1987;10:255\u20136.","journal-title":"Diabetes Care"},{"key":"1623_CR29","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.jemermed.2010.04.007","volume":"41","author":"M Lu","year":"2011","unstructured":"Lu M, Inboriboon PC. Lantus insulin overdose: a case report. J Emerg Med. 2011;41:374\u20137.","journal-title":"J Emerg Med"},{"key":"1623_CR30","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jemermed.2007.02.038","volume":"36","author":"ET Fuller","year":"2009","unstructured":"Fuller ET, Miller MA, Kaylor DW, Janke C. Lantus overdose: case presentation and management options. J Emerg Med. 2009;36:26\u20139.","journal-title":"J Emerg Med"},{"key":"1623_CR31","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3109\/15563658909038579","volume":"27","author":"MH Samuels","year":"1989","unstructured":"Samuels MH, Eckel RH. Massive insulin overdose: detailed studies of free insulin levels and glucose requirements. J Toxicol Clin Toxicol. 1989;27:157\u201368.","journal-title":"J Toxicol Clin Toxicol"},{"key":"1623_CR32","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/S0196-0644(05)80210-0","volume":"22","author":"RJ Roberge","year":"1993","unstructured":"Roberge RJ, Martin TG, Delbridge TR. Intentional massive insulin overdose: recognition and management. Ann Emerg Med. 1993;22:228\u201334.","journal-title":"Ann Emerg Med"},{"key":"1623_CR33","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1111\/j.1464-5491.1994.tb00279.x","volume":"11","author":"P Fasching","year":"1994","unstructured":"Fasching P, Roden M, St\u00fchlinger HG, et al. Estimated glucose requirement following massive insulin overdose in a patient with type 1 diabetes. Diabet Med. 1994;11:323\u20135.","journal-title":"Diabet Med"},{"key":"1623_CR34","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/S1056-8727(00)00057-X","volume":"14","author":"Y Shibutani","year":"2000","unstructured":"Shibutani Y, Ogawa C. Suicidal insulin overdose in a type 1 diabetic patient: relation of serum insulin concentrations to the duration of hypoglycemia. J Diabetes Complic. 2000;14:60\u20132.","journal-title":"J Diabetes Complic"},{"key":"1623_CR35","doi-asserted-by":"publisher","first-page":"e162","DOI":"10.1097\/MJT.0b013e3181f4eadb","volume":"18","author":"TA Mork","year":"2011","unstructured":"Mork TA, Killeen CT, Patel NK, et al. Massive insulin overdose managed by monitoring daily insulin levels. Am J Ther. 2011;18:e162\u20136.","journal-title":"Am J Ther"},{"key":"1623_CR36","doi-asserted-by":"publisher","first-page":"55","DOI":"10.2169\/internalmedicine.39.55","volume":"39","author":"M Matsumura","year":"2000","unstructured":"Matsumura M, Nakashima A, Tofuku Y. Electrolyte disorders following massive insulin overdose in a patient with type 2 diabetes. Intern Med. 2000;39:55\u20137.","journal-title":"Intern Med"},{"key":"1623_CR37","doi-asserted-by":"publisher","first-page":"173","DOI":"10.4103\/0972-5229.128709","volume":"18","author":"A Garg","year":"2014","unstructured":"Garg A, Panda S, Dalvi P, et al. Severe suicidal digoxin and propranolol toxicity with insulin overdose. Indian J Crit Care Med. 2014;18:173\u20135.","journal-title":"Indian J Crit Care Med"},{"key":"1623_CR38","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1258\/rsmmsl.46.3.263","volume":"46","author":"NG Rao","year":"2006","unstructured":"Rao NG, Menezes RG, Nagesh KR, Kamath GS. Suicide by combined insulin and glipizide overdose in a non-insulin dependent diabetes mellitus physician: a case report. Med Sci Law. 2006;46:263\u20139.","journal-title":"Med Sci Law"},{"key":"1623_CR39","doi-asserted-by":"publisher","first-page":"17102101","DOI":"10.4088\/PCC.17l02101","volume":"19","author":"YM Sun","year":"2017","unstructured":"Sun YM, Kamel Y, Amin R, DosSantos M. Intentional insulin overdose for euphoric experience. Prim Care Companion CNS Disord. 2017;19:17102101.","journal-title":"Prim Care Companion CNS Disord"},{"key":"1623_CR40","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1177\/1932296820905593","volume":"14","author":"VN Shah","year":"2020","unstructured":"Shah VN, Forlenza GP. Suicide via intentional insulin overdose through first commercial hybrid closed-loop. J Diabetes Sci Technol. 2020;14:687\u20138.","journal-title":"J Diabetes Sci Technol"},{"key":"1623_CR41","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1177\/070674379403900207","volume":"39","author":"AJ Cooper","year":"1994","unstructured":"Cooper AJ. Attempted suicide using insulin by a non-diabetic: a case study demonstrating the acute and chronic consequences of profound hypoglycemia. Can J Psychiatr. 1994;39:103\u20137.","journal-title":"Can J Psychiatr"},{"key":"1623_CR42","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/S0379-0738(00)00283-8","volume":"113","author":"M Junge","year":"2000","unstructured":"Junge M, Tsokos M, P\u00fcschel K. Suicide by insulin injection in combination with beta-blocker application. Forensic Sci Int. 2000;113:457\u201360.","journal-title":"Forensic Sci Int"},{"key":"1623_CR43","first-page":"365","volume":"8","author":"CI Efrimescu","year":"2013","unstructured":"Efrimescu CI, Yagoub E, Doyle R. Intentional insulin overdose associated with minimal hypoglycemic symptoms in a non-diabetic patient. Maedica (Bucur). 2013;8:365\u20139.","journal-title":"Maedica (Bucur)"},{"key":"1623_CR44","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.legalmed.2019.06.007","volume":"40","author":"V Bugelli","year":"2019","unstructured":"Bugelli V, Campobasso CP, Angelino A, et al. CLEIA of humor vitreous in a case of suicidal insulin overdose. Leg Med (Tokyo). 2019;40:22\u20135.","journal-title":"Leg Med (Tokyo)"},{"issue":"Suppl 1","key":"1623_CR45","first-page":"S120","volume":"16","author":"A Gundgurthi","year":"2012","unstructured":"Gundgurthi A, Kharb S, Dutta MK, et al. Insulin poisoning with suicidal intent. Indian J Endocrinol Metab. 2012;16(Suppl 1):S120\u20132.","journal-title":"Indian J Endocrinol Metab"},{"key":"1623_CR46","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1097\/00000433-200009000-00010","volume":"21","author":"DC Winston","year":"2000","unstructured":"Winston DC. Suicide via insulin overdose in nondiabetics: the New Mexico experience. Am J Forensic Med Pathol. 2000;21:237\u201340.","journal-title":"Am J Forensic Med Pathol"},{"key":"1623_CR47","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1592\/phco.24.14.1412.43147","volume":"24","author":"TS Tofade","year":"2004","unstructured":"Tofade TS, Liles EA. Intentional overdose with insulin glargine and insulin aspart. Pharmacotherapy. 2004;24:1412\u20138.","journal-title":"Pharmacotherapy"},{"key":"1623_CR48","first-page":"1920","volume":"91","author":"Y Thewjitcharoen","year":"2008","unstructured":"Thewjitcharoen Y, Lekpittaya N, Himathongkam T. Attempted suicide by massive insulin injection: a case report and review of literature. J Med Assoc Thai. 2008;91:1920\u20134.","journal-title":"J Med Assoc Thai"},{"key":"1623_CR49","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1097\/00063110-200510000-00007","volume":"12","author":"M Brvar","year":"2005","unstructured":"Brvar M, Mozina M, Bunc M. Prolonged hypoglycaemia after insulin lispro overdose. Eur J Emerg Med. 2005;12:234\u20135.","journal-title":"Eur J Emerg Med"},{"key":"1623_CR50","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1177\/003693300404900311","volume":"49","author":"WS Waring","year":"2004","unstructured":"Waring WS, Alexander WD. Emergency presentation of an elderly female patient with profound hypoglycaemia. Scott Med J. 2004;49:105\u20137.","journal-title":"Scott Med J"},{"key":"1623_CR51","doi-asserted-by":"publisher","first-page":"e28","DOI":"10.1002\/phar.1207","volume":"33","author":"RS Svingos","year":"2013","unstructured":"Svingos RS, Fernandez EM, Reeder DN, Parker JJ. Life-threatening hypoglycemia associated with intentional insulin ingestion. Pharmacotherapy. 2013;33:e28-33.","journal-title":"Pharmacotherapy"},{"key":"1623_CR52","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.3390\/biomedicines10112823","volume":"10","author":"AC Manetti","year":"2022","unstructured":"Manetti AC, Visi G, Spina F, et al. Insulin and oral hypoglycemic drug overdose in post-mortem investigations: a literature review. Biomedicines. 2022;10:2823.","journal-title":"Biomedicines"},{"key":"1623_CR53","doi-asserted-by":"publisher","first-page":"174","DOI":"10.23907\/2016.019","volume":"6","author":"LM Labay","year":"2016","unstructured":"Labay LM, Bitting CP, Legg KM, Logan BK. The determination of insulin overdose in postmortem investigations. Acad Forensic Pathol. 2016;6:174\u201383.","journal-title":"Acad Forensic Pathol"},{"issue":"Suppl 1","key":"1623_CR54","first-page":"S281","volume":"61","author":"N Sunderland","year":"2016","unstructured":"Sunderland N, Wong S, Lee CK. Fatal insulin overdoses: case report and update on testing methodology. J Forensic Sci. 2016;61(Suppl 1):S281\u20134.","journal-title":"J Forensic Sci"},{"key":"1623_CR55","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1093\/jat\/bkz014","volume":"43","author":"KM Legg","year":"2019","unstructured":"Legg KM, Labay LM, Aiken SS, Logan BK. validation of a fully automated immunoaffinity workflow for the detection and quantification of insulin analogs by LC-MS-MS in postmortem vitreous humor. J Anal Toxicol. 2019;43:505\u201311.","journal-title":"J Anal Toxicol"},{"key":"1623_CR56","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1007\/s00414-021-02598-9","volume":"135","author":"C Bottinelli","year":"2021","unstructured":"Bottinelli C, B\u00e9valot F, Cartiser N, et al. Detection of insulins in postmortem tissues: an optimized workflow based on immunopurification and LC-MS\/HRMS detection. Int J Legal Med. 2021;135:1813\u201322.","journal-title":"Int J Legal Med"},{"key":"1623_CR57","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1111\/1556-4029.15219","volume":"68","author":"S Nagasawa","year":"2023","unstructured":"Nagasawa S, Yamaguchi R, Chiba F, et al. Identification, measurement, and evaluation of blood concentrations of insulin glargine and insulin lispro by UPLC-MS-MS in a dead body suspected of insulin overdose. J Forensic Sci. 2023;68:704\u201310.","journal-title":"J Forensic Sci"},{"key":"1623_CR58","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1136\/bmj.285.6346.974-b","volume":"285","author":"DF Levine","year":"1982","unstructured":"Levine DF, Bulstrode C. Managing suicidal insulin overdose. Br Med J (Clin Res Ed). 1982;285:974\u20135.","journal-title":"Br Med J (Clin Res Ed)"},{"key":"1623_CR59","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S0196-0644(84)80513-2","volume":"13","author":"JS Stapczynski","year":"1984","unstructured":"Stapczynski JS, Haskell RJ. Duration of hypoglycemia and need for intravenous glucose following intentional overdoses of insulin. Ann Emerg Med. 1984;13:505\u201311.","journal-title":"Ann Emerg Med"},{"key":"1623_CR60","doi-asserted-by":"publisher","first-page":"R115","DOI":"10.1186\/cc6168","volume":"11","author":"B M\u00e9garbane","year":"2007","unstructured":"M\u00e9garbane B, Deye N, Bloch V, et al. Intentional overdose with insulin: prognostic factors and toxicokinetic\/toxicodynamic profiles. Crit Care. 2007;11:R115.","journal-title":"Crit Care"},{"key":"1623_CR61","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1017\/cem.2017.422","volume":"20","author":"CM Dewaal","year":"2018","unstructured":"Dewaal CM, McGillis E, Mink M, Lucyk S. Octreotide for the treatment of intentional insulin aspart overdose in a non-diabetic patient. CJEM. 2018;20:643\u20137.","journal-title":"CJEM"},{"key":"1623_CR62","doi-asserted-by":"publisher","first-page":"e518","DOI":"10.1002\/ams2.518","volume":"7","author":"T Sakurai","year":"2020","unstructured":"Sakurai T, Harada M, Takahashi T. Successful treatment with artificial pancreas for a patient who attempted suicide using a high-dose insulin s.c. injection. Acute Med Surg. 2020;7:e518.","journal-title":"Acute Med Surg."},{"key":"1623_CR63","doi-asserted-by":"publisher","first-page":"277","DOI":"10.5414\/CPP42277","volume":"42","author":"MA von Mach","year":"2004","unstructured":"von Mach MA, Meyer S, Omogbehin B, et al. Epidemiological assessment of 160 cases of insulin overdose recorded in a regional poisons unit. Int J Clin Pharmacol Ther. 2004;42:277\u201380.","journal-title":"Int J Clin Pharmacol Ther"},{"key":"1623_CR64","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.2337\/diacare.23.7.1023","volume":"23","author":"E Ortega","year":"2000","unstructured":"Ortega E, Wagner A, Caixas A, et al. Hypoglycemia and pulmonary edema: a forgotten association. Diabetes Care. 2000;23:1023\u20134.","journal-title":"Diabetes Care"},{"key":"1623_CR65","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/S0950-351X(05)80210-1","volume":"7","author":"RN Auer","year":"1993","unstructured":"Auer RN, Siesj\u00f6 BK. Hypoglycaemia: brain neurochemistry and neuropathology. Baillieres Clin Endocrinol Metab. 1993;7:611\u201325.","journal-title":"Baillieres Clin Endocrinol Metab"},{"key":"1623_CR66","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1002\/emp2.12093","volume":"1","author":"N Fujisaki","year":"2020","unstructured":"Fujisaki N, Kosaki Y, Nojima T, et al. Glycogenic hepatopathy following attempted suicide by long-acting insulin overdose in patient with type 1 diabetes. J Am Coll Emerg Physicians Open. 2020;1:1097\u2013100.","journal-title":"J Am Coll Emerg Physicians Open"},{"key":"1623_CR67","doi-asserted-by":"publisher","DOI":"10.2174\/0115733998271244231010100747","volume":"20","author":"A Liakos","year":"2024","unstructured":"Liakos A, Karagiannis T, Avgerinos I, et al. Burden and coping strategies of hypoglycemia in people with diabetes. Curr Diabetes Rev. 2024;20: e201023222415.","journal-title":"Curr Diabetes Rev"},{"key":"1623_CR68","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s13300-023-01524-z","volume":"15","author":"S Seidu","year":"2024","unstructured":"Seidu S. A podcast on the use of CGM in optimizing type 2 diabetes management with non-intensive insulin treatment in the primary care setting. Diabetes Ther. 2024;15:301\u20139.","journal-title":"Diabetes Ther"},{"key":"1623_CR69","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1111\/dom.15432","volume":"26","author":"M Marigliano","year":"2024","unstructured":"Marigliano M, Piona C, Mancioppi V, et al. Glucose sensor with predictive alarm for hypoglycaemia: improved glycaemic control in adolescents with type 1 diabetes. Diabetes Obes Metab. 2024;26:1314\u201320.","journal-title":"Diabetes Obes Metab"},{"key":"1623_CR70","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.metabol.2019.06.016","volume":"99","author":"J Farngren","year":"2019","unstructured":"Farngren J, Ahr\u00e9n B. Incretin-based medications (GLP-1 receptor agonists, DPP-4 inhibitors) as a means to avoid hypoglycaemic episodes. Metabolism. 2019;99:25\u201331.","journal-title":"Metabolism"},{"key":"1623_CR71","first-page":"CD012189","volume":"2016","author":"K Hawton","year":"2016","unstructured":"Hawton K, Witt KG, Taylor Salisbury TL, et al. Psychosocial interventions for self-harm in adults. Cochrane Database Syst Rev. 2016;2016:CD012189.","journal-title":"Cochrane Database Syst Rev"},{"key":"1623_CR72","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1111\/papt.12456","volume":"96","author":"K Harris","year":"2023","unstructured":"Harris K, Gooding PA, Awenat Y, et al. Acceptability of a novel suicide prevention psychological therapy for people who experience non-affective psychosis. Psychol Psychother. 2023;96:560\u201376.","journal-title":"Psychol Psychother"},{"key":"1623_CR73","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0247393","volume":"16","author":"L Michaud","year":"2021","unstructured":"Michaud L, Dorogi Y, Gilbert S, Bourquin C. Patient perspectives on an intervention after suicide attempt: the need for patient centred and individualized care. PLoS ONE. 2021;16: e0247393.","journal-title":"PLoS ONE"}],"container-title":["Diabetes Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-024-01623-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13300-024-01623-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-024-01623-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T06:40:03Z","timestamp":1724308803000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13300-024-01623-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,24]]},"references-count":73,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["1623"],"URL":"https:\/\/doi.org\/10.1007\/s13300-024-01623-5","relation":{},"ISSN":["1869-6953","1869-6961"],"issn-type":[{"value":"1869-6953","type":"print"},{"value":"1869-6961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,24]]},"assertion":[{"value":"9 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Evanthia Gouveri has attended conferences sponsored by Berlin-Chemie, Sanofi, AstraZeneca, Novo Nordisk, Lilly and Boehringer Ingelheim; received speaker honoraria by Boehringer-Ingelheim and Menarini. Aikaterini Gkouveri has nothing to disclose. Djordje S. Popovic declares associations with: Abbott, Alkaloid, Amicus, AstraZeneca, Boehringer Ingelheim, Berlin-Chemie, Eli Lilly, Galenika, Krka, Merck, Novo Nordisk, PharmaSwiss, Sanofi-Aventis, Servier, Viatris, and W\u00f6rwag Pharma. Dimitrios Papazoglou declares associations: with Menarini, Novo Nordisk, Astra-Zeneca,\u00a0Boehringer Ingelheim and Sanofi-Aventis. Nikolaos Papanas has been an advisory board member of Astra-Zeneca, Boehringer Ingelheim, Menarini, MSD, Novo Nordisk, Pfizer, Takeda and TrigoCare International; has participated in sponsored studies by Astra-Zeneca, Eli-Lilly, GSK, MSD, Novo Nordisk, Novartis and Sanofi-Aventis; has received honoraria as a speaker for Astra-Zeneca, Boehringer Ingelheim, Eli-Lilly, Elpen, Menarini, MSD, Mylan, Novo Nordisk, Pfizer, Sanofi-Aventis and Vianex; and has attended conferences sponsored by TrigoCare International, Eli-Lilly, Galenica, Novo Nordisk, Pfizer and Sanofi-Aventis. Nikolaos Papanas is an Editorial Board member of Diabetes Therapy. Nikolaos Papanas was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}